Bli medlem
Bli medlem

Du är här

2015-04-22

Novo Nordisk A/S: Novo Nordisk A/S - Reduction of the share capital

Bagsværd, Denmark, 22 April 2015
- At Novo Nordisk's Annual General Meeting on 19 March 2015, it was decided to
reduce the company's B share capital from DKK 422,512,800 to DKK 412,512,800
by cancellation of part of the company's portfolio of own B shares at a
nominal value of DKK 10,000,000 divided into 50,000,000 B shares of DKK 0.20
each.

Further information

---------------------------------------------------------------------
| Media: |
| Anne Margrethe Hauge +45 3079 3450 amhg@novonordisk.com |
| Investors: |
| Kasper Roseeuw Poulsen +45 3079 4303 krop@novonordisk.com |
| Daniel Bohsen +45 3079 6376 dabo@novonordisk.com |
| Melanie Raouzeos +45 3075 3479 mrz@novonordisk.com |
| Frank Daniel Mersebach (US) +1 609 235 8567 fdni@novonordisk.com |
---------------------------------------------------------------------
Company announcement No 27 / 2015

Company announcement no 27 / 2015
http://hugin.info/2013/R/1913419/683321.pdf

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Novo Nordisk A/S via Globenewswire

HUG#1913419

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.